Evidentic • Therapeutic Indications • Adult Crohn's Disease
Adult Crohn’s disease is a chronic relapsing, remitting inflammatory disease of the gastrointestinal tract, the cause of which is unknown. This disease can affect all the gastrointestinal tract discontinuously. Some patients may have continuous clinically active disease.
Showing all 5 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price | |
---|---|---|---|---|---|---|---|---|---|---|
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
11/2019 |
285,00Â € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
08/2019 |
285,00Â € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
02/2020 |
285,00Â € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
03/2021 |
285,00Â € |
||
TNF alpha |
Monoclonal Antibody |
Remicade® |
10 mg/mL |
– |
2 mg |
-80°C |
12/2020 |
285,00Â € |
Let us know about your inquiry details and we’ll contact you shortly.